Co-regulation of microglial subgroups in Alzheimer’s amyloid pathology: Implications for diagnosis and drug development
PLOS One · 05.12.2025 · 20 (12) · e0337741
DOI: 10.1371/journal.pone.0337741 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.12.2025. Verfasst von Yu Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hwamei College of Life and Health Sciences, Zhejiang Wanli University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia. Neuroinflammation drives AD progression and therefore represents a promising target for diagnosis and therapy. In early AD, microglia polarize into pro-inflammatory and anti-inflammatory cellular subgroups that mediate the initial immune response, yet the regulatory relationships between these microglial subgroups remain poorly understood. In this study, we investigated the interplay between pro- and anti-inflammatory microglial subgroups from multiple perspectives. Comparative transcriptomics and bioinformatics analyses implicated the Trem2 signaling pathway in an anti-inflammatory microglial subgroup. Fluorescence-activated cell sorting (FACS) and gene regulation analysis indicated that microglial subgrouping and microgliosis preceded cytokine upregulation during early amyloid pathology. Further immunoassays revealed that anti-inflammatory Neurodegeneration-Related Modules and pro-inflammatory microglial subgroups, Interferon-Related Modules and LPS-Related Modules, were co-regulated by shared upstream pro-inflammatory regulators. Such co-regulation of heterogeneous microglial subgroups may balance microglial activation and promote the development of AD chronic neuroinflammation. In summary, our study uncovered previously overlooked co-regulation of microglial subgroups in AD and provides a systems biology framework that may inform improved diagnostic markers and immunotherapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hwamei College of Life and Health Sciences, Zhejiang Wanli University, Ningbo, Zhejiang, China.
ORCID-Profile: Feng Xue
Zitieren
APA
Zhou, Y., Huang, Y., Fan, Y., & Xue, F. (2025). Co-regulation of microglial subgroups in Alzheimer’s amyloid pathology: Implications for diagnosis and drug development. PLOS One, 20(12), e0337741. https://doi.org/10.1371/journal.pone.0337741
Vancouver
Zhou Y, Huang Y, Fan Y, Xue F. Co-regulation of microglial subgroups in Alzheimer’s amyloid pathology: Implications for diagnosis and drug development. PLOS One. 2025;20(12):e0337741. doi:10.1371/journal.pone.0337741
BibTeX
@article{Zhou2025,
author = {Zhou, Yu and Huang, Yukuan and Fan, Yangchang and Xue, Feng},
title = {Co-regulation of microglial subgroups in Alzheimer’s amyloid pathology: Implications for diagnosis and drug development},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {12},
pages = {e0337741},
doi = {10.1371/journal.pone.0337741}
}
EUVIMED